Literature DB >> 26987701

Defeating Alzheimer's disease and other dementias: a priority for European science and society.

Bengt Winblad1, Philippe Amouyel2, Sandrine Andrieu3, Clive Ballard4, Carol Brayne5, Henry Brodaty6, Angel Cedazo-Minguez7, Bruno Dubois8, David Edvardsson9, Howard Feldman10, Laura Fratiglioni11, Giovanni B Frisoni12, Serge Gauthier13, Jean Georges14, Caroline Graff15, Khalid Iqbal16, Frank Jessen17, Gunilla Johansson7, Linus Jönsson7, Miia Kivipelto18, Martin Knapp19, Francesca Mangialasche11, René Melis20, Agneta Nordberg21, Marcel Olde Rikkert20, Chengxuan Qiu11, Thomas P Sakmar22, Philip Scheltens23, Lon S Schneider24, Reisa Sperling25, Lars O Tjernberg7, Gunhild Waldemar26, Anders Wimo7, Henrik Zetterberg27.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 26987701     DOI: 10.1016/S1474-4422(16)00062-4

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  428 in total

1.  An Alternative Approach to Study Primary Events in Neurodegeneration Using Ex Vivo Rat Brain Slices.

Authors:  Emanuele Brai; Antonella Cogoni; Susan A Greenfield
Journal:  J Vis Exp       Date:  2018-04-11       Impact factor: 1.355

2.  Screening of Synthetic Isoxazolone Derivative Role in Alzheimer's Disease: Computational and Pharmacological Approach.

Authors:  Meissam Ali; Uzma Saleem; Fareeha Anwar; Muhammad Imran; Humaira Nadeem; Bashir Ahmad; Tahir Ali; Tariq Ismail
Journal:  Neurochem Res       Date:  2021-01-24       Impact factor: 3.996

Review 3.  [Innovation in diagnostics-mobile technologies].

Authors:  Emrah Düzel; Jochen René Thyrian; David Berron
Journal:  Nervenarzt       Date:  2019-09       Impact factor: 1.214

4.  Societal and global implications of the "dementia epidemic": the example of the London Heathrow airport.

Authors:  Marco Canevelli; Alessandro Blasimme; Matteo Cesari
Journal:  Eur J Epidemiol       Date:  2017-01-02       Impact factor: 8.082

5.  Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype.

Authors:  Lisa Vermunt; Sietske A M Sikkes; Ardo van den Hout; Ron Handels; Isabelle Bos; Wiesje M van der Flier; Silke Kern; Pierre-Jean Ousset; Paul Maruff; Ingmar Skoog; Frans R J Verhey; Yvonne Freund-Levi; Magda Tsolaki; Åsa K Wallin; Marcel Olde Rikkert; Hilkka Soininen; Luisa Spiru; Henrik Zetterberg; Kaj Blennow; Philip Scheltens; Graciela Muniz-Terrera; Pieter Jelle Visser
Journal:  Alzheimers Dement       Date:  2019-06-01       Impact factor: 21.566

Review 6.  The quantitative neuroradiology initiative framework: application to dementia.

Authors:  Olivia Goodkin; Hugh Pemberton; Sjoerd B Vos; Ferran Prados; Carole H Sudre; James Moggridge; M Jorge Cardoso; Sebastien Ourselin; Sotirios Bisdas; Mark White; Tarek Yousry; John Thornton; Frederik Barkhof
Journal:  Br J Radiol       Date:  2019-08-01       Impact factor: 3.039

7.  The anteroposterior and primary-to-posterior limbic ratios as MRI-derived volumetric markers of Alzheimer's disease.

Authors:  Adolfo Jiménez-Huete; Susana Estévez-Santé
Journal:  J Neurol Sci       Date:  2017-04-27       Impact factor: 3.181

Review 8.  Multimorbidity and functional impairment-bidirectional interplay, synergistic effects and common pathways.

Authors:  A Calderón-Larrañaga; D L Vetrano; L Ferrucci; S W Mercer; A Marengoni; G Onder; M Eriksdotter; L Fratiglioni
Journal:  J Intern Med       Date:  2018-11-22       Impact factor: 8.989

9.  Association of Cardiovascular Health Level in Older Age With Cognitive Decline and Incident Dementia.

Authors:  Cécilia Samieri; Marie-Cécile Perier; Bamba Gaye; Cécile Proust-Lima; Catherine Helmer; Jean-François Dartigues; Claudine Berr; Christophe Tzourio; Jean-Philippe Empana
Journal:  JAMA       Date:  2018-08-21       Impact factor: 56.272

10.  Legumain Knockout Protects Against Aβ1-42-Induced AD-like Cognitive Deficits and Synaptic Plasticity Dysfunction Via Inhibiting Neuroinflammation Without Cleaving APP.

Authors:  Runwen Chen; Qiyue Zhang; Yuxing Yan; Yuying Zhang; Tao Zhang
Journal:  Mol Neurobiol       Date:  2020-11-21       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.